AzTrials
AzTrials

Typical DevelopmentTICOALA-SOINSNCT07283458

Assessment of Language Comprehension and Learning in Children Attending Child Psychiatry Services (TICOALA-SOINS)

A study testing TICOALA in people with Typical Development and Typically Developing Children Ages 3 to 6, run by Centre Hospitalier St Anne at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Language is central to children's cognitive, emotional, and social development, and language difficulties are a frequent reason for consultation in child psychiatry, often co-occurring with psychiatric disorders. Read more about this study

Who is it for?
Ages 3 to 7 yearsHealthy volunteers can take part
What is being tested?
TICOALA
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteFrance
Study dates
19 Mar 2026to 19 Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 7 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children (boys or girls) aged 3-7 years
  • Consulting in the child psychiatry service
  • Enrolled in a French-speaking school

Who cannot join

  • Inability to use the tablet-based TICOALA tool due to severe sensory (blindness, deafness), motor, or intellectual impairment
  • Refusal of the child or parents/legal guardians to participate
  • Child not affiliated with the French social security system

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Khaoussou SYLLA, Dr contact

+33145658486

K.SYLLA@ghu-paris.fr

France1 site, 1 recruiting
  • Barabara BONNEL

    Paris, 75014

    Barabara BONNEL, barbara.bonnel@ghu-paris.fr

    Maryse LEVY-RUEFF, Dr, M.LEVY-RUEFF@ghu-paris.fr

    Recruiting

Other trials in France

About this study

Official title: TICOALA-SOINS : Assessment of Language Comprehension and Learning in Children Attending Child Psychiatry Services. Pilot Study of Acceptability and Feasibility.

Language is central to children's cognitive, emotional, and social development, and language difficulties are a frequent reason for consultation in child psychiatry, often co-occurring with psychiatric disorders. Yet, systematic language assessment is rarely possible due to the limited availability of speech-language therapists in these services.

The TICOALA tool (Interactive Test of Language Comprehension and Learning on tablet) offers a quick and engaging way to evaluate lexical and syntactic comprehension and word learning. This study aims to assess its acceptability among children aged 3-7 attending a child psychiatry service in Paris, as well as among clinicians and parents. Secondary goals include testing the feasibility of a larger study, describing children's language skills, and examining how these relate to clinical and background variables.

Read the detailed description

Language is intrinsically linked to children's cognitive, social, emotional, and psychological development, and plays a crucial role in both academic achievement and psychosocial adjustment. In child psychiatry, language difficulties are a common reason for consultation and are frequently associated with psychiatric conditions such as anxiety disorders or attention difficulties. However, due to the limited availability of speech-language therapists in these settings, systematic language assessments are rarely conducted.

The TICOALA tool (Interactive Test of Language Comprehension and Learning on tablet) offers a quick and engaging way to evaluate children's lexical and syntactic comprehension, as well as their ability to learn new words. Integrating this tool into clinical practice could provide an initial language assessment and help guide referrals for formal speech-language evaluation.

Main Objective To assess the acceptability of the TICOALA tool among children attending our child psychiatry service.

Secondary Objectives

  • To evaluate its acceptability for clinicians (psychiatrists, psychologists) and parents.
  • To assess the acceptability of the parental clinical questionnaire.
  • To determine the feasibility of conducting a larger-scale study.
  • To describe the language skills (lexical, syntactic, word learning) of children in our service.
  • To analyze the relationship between language skills and clinical/anamnestic data (socio-economic background, play and screen exposure, language experience, etc.).

Target Population Children aged 3-7 years consulting at the child psychiatry service in the 14th arrondissement of Paris.

Being tested
TICOALA
Keywords
language assessment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TICOALAOther

    The TICOALA tool (Interactive Test of Language Comprehension and Learning on tablet) offers a quick and engaging way to evaluate children's lexical and syntactic comprehension, as well as their ability to learn new words. Integrating this tool into clinical practice could provide an initial language assessment and help guide referrals for formal speech-language evaluation.

Study groups in NCT07283458
Study groupRoleWhat they receive
Children with language comprehension and learning difficultiesOtherNot described
Receives: Other: TICOALA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability of the TICOALA tool among children attending our child psychiatry service

    This objective will be evaluated using a questionnaire with a 5-point Likert scale, with a composite evaluation criterion based on three elements: the child's opinion, their level of attention, and their level of motivation. The questionnaire will be completed by the consultant, reporting the child's opinion and their clinical observations (attention, motivation) during the assessment.

    Measured: 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Dec 2025
  2. Study start19 Mar 2026
  3. Primary completion19 Mar 2028 (estimated)
  4. Study completion19 Mar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07283458
Sponsor's protocol ID
D25-P001
Acronym
TICOALA-SOINS
Status last verified
Oct 2025
First submitted
20 Nov 2025
Last updated
21 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Only anonimyzed results will be shared. Each child will be assigned a code. Data shared will simply include scores on the tasks and answers in the questionnaires without any information linked to each individual identity.

Questions about this trial

What is this clinical trial studying?

A study testing TICOALA in people with Typical Development and Typically Developing Children Ages 3 to 6, run by Centre Hospitalier St Anne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Khaoussou SYLLA, Dr (+33145658486, K.SYLLA@ghu-paris.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability of the TICOALA tool among children attending our child psychiatry service (time frame: 4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in